3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
Leukemia, Myeloid, Acute
2
HIV Infections
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Anus Neoplasms
2
Solitary Fibrous Tumor, Pleural
1
Smoldering Multiple Myeloma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Prostate Adenocarcinoma
1
Precancerous Conditions
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Melanoma
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Liposarcoma
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leiomyosarcoma
1
Interventions
Ipilimumab
6
pembrolizumab
5
Nivolumab
5
Dacarbazine
5
CTLA-4 Antigen
4
Carboplatin
3
Bevacizumab
3
relatlimab
2
aflibercept
2
Temozolomide
2
Ranibizumab
2
Radiosurgery
2
Paclitaxel
2
Lenalidomide
2
Immunoglobulin G
2
Embolization, Therapeutic
2
Disulfides
2
Cyclophosphamide
2
Colony-Stimulating Factors
2
Albumin-Bound Paclitaxel
2
AZD 6244
2
130-nm albumin-bound paclitaxel
2
utomilumab
1
ulixertinib
1
trametinib
1
tebentafusp
1
sotrastaurin
1
sargramostim
1
poly ICLC
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uveal Melanoma
×
Watchful Waiting
×
Clear all
No trials found.